Side-by-side comparison of AI visibility scores, market position, and capabilities
Allentown PA industrial gases and clean hydrogen (NYSE: APD) $12.1B FY2024 revenue; NEOM green hydrogen $8.5B megaproject, CEO transition Oct 2024, Mantle Ridge activism competing with Linde and Air Liquide.
Air Products and Chemicals, Inc. is an Allentown, Pennsylvania-based industrial gases and energy transition company — publicly traded on the New York Stock Exchange (NYSE: APD) as an S&P 500 Materials component — producing and distributing atmospheric gases (oxygen, nitrogen, argon), process gases (hydrogen, helium, carbon dioxide), and specialty gases for industrial, healthcare, and clean energy applications through approximately 22,000 employees in 50+ countries. In fiscal year 2024 (ending September 2024), Air Products reported revenues of $12.1 billion with adjusted EBITDA of approximately $3.9 billion, as the company continued executing its massive green hydrogen mega-project portfolio despite significant capital deployment raising Net Debt-to-EBITDA above 4x. In October 2024, longtime CEO Seifi Ghasemi retired after a decade leading Air Products' transformation from a traditional industrial gases company to a clean hydrogen investment vehicle — Eduardo Menezes was appointed CEO, with activist investor Mantle Ridge (holding approximately 10% of Air Products shares) advocating for strategic refocus, capital discipline, and potential strategic alternatives to the green hydrogen mega-project strategy. Air Products' industrial gases business (oxygen for steel production, nitrogen for food preservation and semiconductor manufacturing, hydrogen for petroleum refining) generates $8+ billion in recurring revenues from long-term take-or-pay contracts with petrochemical, steel, and healthcare customers — providing the cash flow foundation that supports green hydrogen capital investment.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.